Alkem Lab

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE540L01014
  • NSEID: ALKEM
  • BSEID: 539523
INR
5,445.85
147.65 (2.79%)
BSENSE

Mar 25

BSE+NSE Vol: 34.7 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1000019,
    "name": "Alkem Lab",
    "stock_name": "Alkem Lab",
    "full_name": "Alkem Laboratories Ltd",
    "name_url": "stocks-analysis/alkem-lab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "5,445.85",
    "chg": 147.65,
    "chgp": "2.79%",
    "dir": 1,
    "prev_price": "5,298.20",
    "mcapval": "65,113.31 Cr",
    "mcap": "Mid Cap",
    "scripcode": 539523,
    "symbol": "ALKEM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE540L01014",
    "curr_date": "Mar 25",
    "curr_time": "",
    "bse_nse_vol": "34.7 k",
    "exc_status": "Active",
    "traded_date": "Mar 25, 2026",
    "traded_date_str": "2026 03 25",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alkem-lab-1000019-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-mixed-technical-signals-3910795",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_oi_spurts_by_underlying_3910795.png",
        "date": "2026-03-24 15:00:44",
        "description": "Alkem Laboratories Ltd has witnessed a significant 22.4% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock trades below all major moving averages, reflecting underlying caution amid mixed technical and fundamental cues."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-mixed-technical-signals-3910667",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_oi_spurts_by_underlying_3910667.png",
        "date": "2026-03-24 14:00:39",
        "description": "Alkem Laboratories Ltd has witnessed a significant 17.9% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite the stock’s recent outperformance relative to its sector, technical indicators and volume patterns suggest a complex interplay of bullish and cautious sentiment among traders."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-mixed-technical-signals-3910535",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_oi_spurts_by_underlying_3910535.png",
        "date": "2026-03-24 13:00:28",
        "description": "Alkem Laboratories Ltd has witnessed a notable 14.4% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this increase, the stock trades below all major moving averages, reflecting a cautious outlook amid mixed volume and delivery trends."
      },
      {
        "title": "Alkem Laboratories Declines 1.75%: Technical Weakness and Flat Financials Weigh",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-declines-175-technical-weakness-and-flat-financials-weigh-3905251",
        "imagepath": "",
        "date": "2026-03-21 14:02:17",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Mar:</strong> Mojo Grade downgraded to Sell amid mixed financial and technical signals</p>\n                    <p><strong>16 Mar:</strong> Mildly bearish technical shift confirmed with mixed momentum indicators</p>\n                    <p><strong>19 Mar:</strong> Sharp intraday decline of 2.02% on heavy volume</p>\n                    <p><strong>20 Mar:</strong> Slight recovery with 0.32% gain, week closes at Rs.5,257.75</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.5,351.50</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label..."
      },
      {
        "title": "Alkem Laboratories Downgraded to Sell Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alkem-laboratories-downgraded-to-sell-amid-mixed-financial-and-technical-signals-3892850",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_mojoScore_3892850.png",
        "date": "2026-03-16 08:11:08",
        "description": "Alkem Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 13 March 2026. This revision reflects a combination of deteriorating technical indicators, flat recent financial performance, and concerns over long-term growth prospects despite solid management efficiency and fair valuation metrics."
      },
      {
        "title": "Alkem Laboratories Ltd Faces Mildly Bearish Technical Shift Amid Mixed Momentum Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-faces-mildly-bearish-technical-shift-amid-mixed-momentum-signals-3892759",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_technicaldot_3892759.png",
        "date": "2026-03-16 08:02:39",
        "description": "Alkem Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a recent downgrade from Hold to Sell by MarketsMOJO, the stock exhibits a complex interplay of technical indicators, reflecting both cautious investor sentiment and pockets of resilience."
      },
      {
        "title": "Alkem Laboratories Ltd Faces Technical Momentum Shift Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-faces-technical-momentum-shift-amid-mixed-indicator-signals-3888122",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_technicaldot_3888122.png",
        "date": "2026-03-13 08:02:24",
        "description": "Alkem Laboratories Ltd has experienced a notable shift in price momentum, with technical indicators signalling a transition from a mildly bullish trend to a sideways movement. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the pharmaceutical mid-cap continues to demonstrate resilience amid mixed signals from MACD, RSI, and moving averages, reflecting a complex market environment for investors."
      },
      {
        "title": "Alkem Laboratories Ltd Shows Mildly Bullish Momentum Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-shows-mildly-bullish-momentum-amid-mixed-technical-signals-3884410",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_technicaldot_3884410.png",
        "date": "2026-03-11 08:03:15",
        "description": "Alkem Laboratories Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, and moving averages, suggesting cautious optimism for investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Alkem Laboratories Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alkem-laboratories-ltd-is-rated-hold-by-marketsmojo-3882704",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlkemLaboratori_mojoScore_3882704.png",
        "date": "2026-03-10 10:10:02",
        "description": "Alkem Laboratories Ltd is currently rated 'Hold' by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 520,
    "sid": "1000019",
    "stock_news_url": "https://www.marketsmojo.com/news/alkem-laboratories-1000019"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "21-Mar-2026",
      "details": "Please find attached herewith Press release on Alkem launches Semaglutide injection in India with weekly therapy starting at INR 450/-",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "20-Mar-2026",
      "details": "Please find attached herewith Intimation regarding receipt of EU GMP Certificate for the Company manufacturing facility located at Daman India.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "20-Mar-2026",
      "details": "Please find enclosed herewith the details of the Analyst / Investor meeting to be held on 26th March2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Alkem Laboratories Ltd has declared <strong>2150%</strong> dividend, ex-date: 20 Feb 26",
          "dt": "2026-02-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Alkem Laboratories Declines 1.75%: Technical Weakness and Flat Financials Weigh

2026-03-21 14:02:17

Key Events This Week

16 Mar: Mojo Grade downgraded to Sell amid mixed financial and technical signals

16 Mar: Mildly bearish technical shift confirmed with mixed momentum indicators

19 Mar: Sharp intraday decline of 2.02% on heavy volume

20 Mar: Slight recovery with 0.32% gain, week closes at Rs.5,257.75

stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Press Release / Media Release

21-Mar-2026 | Source : BSE

Please find attached herewith Press release on Alkem launches Semaglutide injection in India with weekly therapy starting at INR 450/-

Announcement under Regulation 30 (LODR)-Press Release / Media Release

20-Mar-2026 | Source : BSE

Please find attached herewith Intimation regarding receipt of EU GMP Certificate for the Company manufacturing facility located at Daman India.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

20-Mar-2026 | Source : BSE

Please find enclosed herewith the details of the Analyst / Investor meeting to be held on 26th March2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Alkem Laboratories Ltd has declared 2150% dividend, ex-date: 20 Feb 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available